Esperion to Report First Quarter 2026 Financial Results on May 7

Go back to Esperion to Report First Quarter 2026 Financial Results on May 7
ESPERION THERAP (NASDAQ: ESPR) Delayed: 3.16 --0 (-0%)
Previous Close $3.16    52 Week High $30.41 
Open $3.16    52 Week Low $9.40 
Day High $3.17    P/E N/A 
Day Low $3.15    EPS $-21.87 
Volume 2,931,723